![Keith Lenden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Lenden
Amministratore Delegato presso
Kisbee Therapeutics, Inc.
Profilo
Keith F.
Lenden is the founder of Receptos LLC, founded in 2008.
Mr. Lenden is the founder of Abide Therapeutics, Inc., founded in 2011.
Mr. Lenden is the founder of Asteroid Therapeutics, Inc., founded in 2021, and holds the titles of Secretary, Chief Executive & Financial Officer.
Mr. Lenden is also the founder of The Henry J.
Kaiser Family Foundation,Autobahn Therapeutics, Inc...
Mr. Lenden is Chief Executive Officer & Director at Kisbee Therapeutics, Inc. Mr. Lenden is Director at Genuity Science, Inc. Former positions include Chief Executive Officer, CFO, Secretary & Director at Boundless Bio, Inc.; Senior Director-Business Development at Acologix, Inc.; Director-Business Development at Genteric, Inc.; Venture Partner at ARCH Venture Partners LLC from 2017 to 2025; Vice President-Product & Business Development at Maxygen, Inc.; VP-Corporate Development & Strategy at Esperion Therapeutics, Inc.; and Consultant at L.E.K.
Consulting LLP from 1995 to 1999.
Education includes undergraduate degrees from Dartmouth College and Thayer School of Engineering At Dartmouth in 1995, an MBA from Haas School of Business, and an MBA from the University of California in 2001.
Posizioni attive di Keith Lenden
| Società | Posizione | Inizio |
|---|---|---|
Genuity Science, Inc.
 Genuity Science, Inc. Packaged SoftwareTechnology Services Develops cloud based programs to improve health and support wellness | Direttore/Membro del Consiglio | - |
Asteroid Therapeutics, Inc.
 Asteroid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio technology business | Amministratore Delegato | 01/07/2021 |
Kisbee Therapeutics, Inc.
 Kisbee Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapeutic agents for neurodegenerative diseases | Amministratore Delegato | - |
Precedenti posizioni note di Keith Lenden
| Società | Posizione | Fine |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Investitore di Private Equity | 31/12/2025 |
| BOUNDLESS BIO, INC. | Amministratore Delegato | 19/05/2019 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2015 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Corporate Officer/Principal | 26/11/2013 |
L.E.K. Consulting LLP
 L.E.K. Consulting LLP Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Consulente / Consigliere | 01/08/1999 |
Formazione di Keith Lenden
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
93
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Acologix, Inc.
 Acologix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
The Henry J. Kaiser Family Foundation
 The Henry J. Kaiser Family Foundation Investment Trusts/Mutual FundsMiscellaneous Profile Unavailable. | Miscellaneous |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Health Technology |
L.E.K. Consulting LLP
L.E.K. Consulting LLP Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thayer School of Engineering At Dartmouth
 Thayer School of Engineering At Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genuity Science, Inc.
Genuity Science, Inc. Packaged SoftwareTechnology Services Develops cloud based programs to improve health and support wellness | Technology Services |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Health Technology |
Kisbee Therapeutics, Inc.
Kisbee Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapeutic agents for neurodegenerative diseases | Health Technology |
Asteroid Therapeutics, Inc.
Asteroid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio technology business | Health Technology |
